Baicalin maintains late-stage functional cardiomyocytes in embryoid bodies derived from murine embryonic stem cells

Cell Physiol Biochem. 2013;32(1):86-99. doi: 10.1159/000350127. Epub 2013 Jul 5.

Abstract

Background/aims: Low efficiency of cardiomyocyte (CM) differentiation from embryonic stem (ES) cells limits their therapeutic use. The objective of this study was to investigate the effect of baicalin, a natural flavonoid compound, on the in vitro cardiac differentiation of murine ES cells.

Methods: The induction of ES cells into cardiac-like cells was performed by embryoid body (EB)-based differentiation method. The electrophysiological properties of the ES cell-derived CMs (ES-CMs) were measured by patch-clamp. The biomarkers of ES-CMs were determined by quantitative RT-PCR and immunofluorescence.

Results: Continuous baicalin treatment decreased the size of EBs, and increased the proportion of α-actinin-positive CMs and transcript level of cardiac specific markers in beating EBs by inducing cell death of non-CMs. Baicalin increased the percentage of working ES-CMs which had typical responses to β-adrenergic and muscarinic stimulations.

Conclusion: Baicalin maintains the late-stage functional CMs in EBs derived from murine ES cells. This study describes a new insight into the various biological effects of baicalin on cardiac differentiation of pluripotent stem cells.

MeSH terms

  • Animals
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Embryoid Bodies / drug effects*
  • Embryonic Stem Cells / cytology*
  • Flavonoids / pharmacology*
  • Mice
  • Myocytes, Cardiac / cytology*
  • Myocytes, Cardiac / metabolism

Substances

  • Flavonoids
  • baicalin